SPY313.78-3.28 -1.03%
DIA259.04-3.84 -1.46%
IXIC10,343.89-89.76 -0.86%

B. Riley FBR Maintains Buy on Novavax, Raises Price Target to $106

B. Riley FBR analyst Mayank Mamtani maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $74 to $106.

Benzinga · -
B. Riley FBR analyst Mayank Mamtani maintains Novavax (NASDAQ: NVAX) with a Buy and raises the price target from $74 to $106.